arrow
C

Christopher J. Ormandy

The Kinghorn Cancer Centre
H指数:62
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo

ALTEN: 一个用于评估体外细胞反应的高保真初级组织工程平台

2022-05-253
OAAI
NSG-Pro mouse model for uncovering resistance mechanisms and unique vulnerabilities in human luminal breast cancers
2021-09-1712
OAAI
Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype
2021-04-0135
OAAI
Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer

基底细胞样乳腺癌分化抑制因子4 (ID4) 的蛋白质组学分析

2020-06-117
OAAI
ELF5 modulates the estrogen receptor cistrome in breast cancer

ELF5调节乳腺癌中的雌激素受体cistrome

2020-01-0220
OAAI
MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma

MCL-1拮抗作用增强达沙替尼对胰腺癌的抗侵袭作用

2019-11-1818
OAAI
A mutation in the viral sensor 2′-5′-oligoadenylate synthetase 2 causes failure of lactation
2017-11-0815
OAAI
A RhoA-FRET Biosensor Mouse for Intravital Imaging in Normal Tissue Homeostasis and Disease Contexts

RhoA-FRET生物传感器小鼠,用于在正常组织稳态和疾病背景下进行活体成像

2017-10-0176
OAAI
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis

通过ROCK抑制的瞬时组织启动可使胰腺癌的进展,对化学疗法的敏感性和转移脱钩

2017-04-05211
OAAI
MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib
2016-12-0871
OAAI